Spanish plant-based protein producer Heura closes Series B financing
Spanish Food tech Start-up Heura Foods secures €40m in Series B financing round to expand product distribution.<br /><br /><br />
Spanish plant-based protein producer Heüra Foods closes Series B financing
Spanish Food tech Start-up Heüra Foods secures €40m in Series B financing round to expand product distribution.<br /><br /><br />
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN
Biovian and 3P Biopharmaceuticals have created a new pan-European CDMO, dubbed 3PBIOVIAN. <h2></h2> <h2></h2>
Lonza and Oxford Nanopore collaborate to advance mRNA Therapeutics
To improve mRNA product analysis, the Lonza Group Ltd. and Oxford Nanopore Technologies plc. are working together to develop and market a test to assess multiple critical quality attributes of […]
£26m for Cystic Fibrosis Drug Trial
Enterprise Therapeutics Ltd. has raised £26m for the Phase IIa trial of ETD001, a novel cystic fibrosis treatment, with investment led by Panakes Partners and participation from existing investors.
Alvotech Advances in Biosimilar Market with Successful AVT03 Study
AVT03, a biosimilar candidate for osteoporosis treatment, showed promise in treating bone illnesses, according to results from a pharmacokinetic study by Alvotech SA.
Novozymes and Chr. Hansen Complete Merger, Forming Novonesis
Danish Novozymes A/S and Chr. Hansen Holding A/S have completed their merger, creating a new company named Novonesis.
2:1 for new genomic techniques
Following the AGRI Committee of the European Parliament, the lead ENVI Committee has also agreed to relax the rules for the authorisation of NGTs.
Innate immunity merger raises €75m
Forbion has spearheaded a €75m Series A financing in Norwegian biotech Calluna Pharma. The clinical-stage company resulted from the merger of Oxitope Pharma and Arxx Therapeutics.
Roche jumps ship on AC Immune
<span style="mso-ansi-language:EN-GB" lang="EN-GB">Genentech, Roche’s US subsidiary, is ending its decades-long collaboration with <link https://www.acimmune.com _blank>AC Immune SA</link> after disappointing study results. It has handed the global rights to Crenezumab and […]